ABCL - AbCellera Biologics EPS misses by $0.02 misses on revenue November, 09 2021 04:12 PM AbCellera Biologics Inc. AbCellera Biologics (NASDAQ:ABCL): Q3 GAAP EPS of -$0.08 misses by $0.02. Revenue of $5.51M (-41.1% Y/Y) misses by $4.49M. Press Release For further details see: AbCellera Biologics EPS misses by $0.02, misses on revenue